May 3, 2018 / 11:43 AM / 22 days ago

BRIEF-Avenue Therapeutics Reports Q1 Loss Per Share Of $1.03

May 3 (Reuters) - Avenue Therapeutics Inc:

* AVENUE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS

* Q1 LOSS PER SHARE $1.03

* AS OF MARCH 31, 2018, CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TOTALED $15.0 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below